Point-of-care testing system for rapid, accurate detection and personalized health assessment. Integrates precision detection technology with health management protocols for decentralized diagnostic applications.
Manufactured by
Nanjing, China
About Eaglenos Eaglenos Sciences, Inc., founded in 2018, specializes in the development, manufacturing and marketing of point-of-care diagnostic devices for nearpatient testing and home care. Powered by cutting edge technologies in electrochemistry, microfluidics, signal acquisition, and automation, Eaglenos has quickly become a leading force in precise POCT products targeting diabetes, hyperuricemia, cardiovascular, cerebrovascular diseases and acute care testing. We have successfully launched blood gas analysis system, electrolyte analysis system, blood glucose/lactate/ketone/uric acid/ total cholesterol/creatinine test systems, and most recently continuous monitoring devices. Eaglenos has since obtained the ISO system certification, more than 20 NMPA certificates, FDA device listing, CE IVDD others and IVDR A certificates. Inspired by our core values of “quality, innovation, cooperation and accountability” , Eaglenos is committed to providing top quality diagnostic products and digital systems for a better, healthier life. What we do Eaglenos specializes in developing diagnostic devices tailored for home care and bedside testing. From acute care blood testing systems, to selfmonitoring meters and wearable devices for chronic diseases, our product lineup includes blood gas biochemical analyzers, electrolyte analyzers, versatile meters for blood glucose, lactate, ketone, creatinine, total cholesterol, and uric acid, as well as continuous glucose monitoring devices. Eaglenos electrochemical technology is distinguished by its unparalleled sensitivity, stability, rapid detection time, and minimal sample requirements. It seamlessly incorporates intricate functional elements from analytical laboratories into compact devices, ensuring an expeditious and user-friendly experience.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Dymind Biotechnology Co.,Ltd.
China · 2 relevant products
Response Biomedical
Canada · 1 relevant product
Corelax UK Ltd
United Kingdom · 1 relevant product
Winnoz Technology, Inc.
Taiwan · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Suzhou Molarray Co., Ltd.
China · 1 relevant product
Bioperfectus
China · 1 relevant product
Shenzhen Refresh Biosensing Technology Co., Ltd.
China · 1 relevant product
IDNEO TECHNOLOGIES S.A.U.
Spain · 6 relevant products
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 71 closest product alternatives
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Rapid diagnostic testing system for immediate bedside and clinic-based testing. Enables quick clinical decision-making in emergency and primary care settings.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Point-of-care testing platform for rapid disease detection and immediate clinical decision-making at bedside or clinic.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
Corelax UK Ltd · United Kingdom
Advanced point-of-care testing system developed through extensive research and development in diagnostic technologies. Designed for accurate healthcare diagnostic services in clinical settings.
Winnoz Technology, Inc. · Taiwan
Winnoz's decentralized healthcare platform enabling screening and diagnostic testing in remote locations, clinics, pharmacies, and home settings. The platform supports diverse panel tests including lipid, liver, and molecular POCT with expedited treatment decision-making capabilities.
Guangzhou Wondfo Biotech Co., Ltd. · China
Point-of-care testing platform utilizing colloidal gold technology for rapid diagnostic applications. Enables quick detection and quantification of analytes in clinical settings without requiring laboratory infrastructure.
Suzhou Molarray Co., Ltd. · China
A point-of-care testing platform for rapid molecular diagnostics at the site of patient care. The system enables quick detection of pathogens and genetic markers without requiring centralized laboratory infrastructure.
Bioperfectus · China
Rapid point-of-care testing platform for detection of infectious disease markers at the bedside or clinic. Enables quick diagnosis without centralized laboratory infrastructure.
Shenzhen Refresh Biosensing Technology Co., Ltd. · China
A point-of-care testing platform for molecular diagnostics in clinical and field settings. The system provides rapid diagnostic results for precision medical applications.
IDNEO TECHNOLOGIES S.A.U. · Spain
Point of Care diagnostic platform enabling real-time patient testing and monitoring at the bedside or clinical setting. Delivers rapid results to support immediate clinical decision-making and patient management across acute and primary care environments.
guangzhou biotron technolongy co.,ltd · China
Point-of-care testing platform based on immunochemical principles for rapid on-site diagnostic testing without laboratory infrastructure requirements.
Assure Tech. (Hangzhou) Co., Ltd. · China
POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.
59 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products